STOCK TITAN

Gohealth, Inc. Stock Price, News & Analysis

GOCO Nasdaq

Welcome to our dedicated page for Gohealth news (Ticker: GOCO), a resource for investors and traders seeking the latest updates and insights on Gohealth stock.

GoHealth, Inc. (GOCO) is a leader in Medicare-focused digital health solutions, combining machine learning with insurance expertise to simplify healthcare decisions. This page serves as the definitive source for official company announcements and developments.

Access real-time updates on earnings reports, strategic partnerships, regulatory compliance changes, and technological advancements. Investors and industry observers will find curated press releases detailing operational milestones, consumer initiatives, and market expansions.

Our news collection prioritizes transparency, offering insights into GoHealth's data-driven approach to Medicare plan matching and its network of licensed agents. Key coverage areas include product innovations, consumer education programs, and responses to healthcare industry trends.

Bookmark this page for direct access to verified information about GOCO's Medicare solutions and corporate developments. Regularly updated to reflect the company's evolving role in transforming health insurance navigation through technology.

Rhea-AI Summary

GoHealth Inc. (NASDAQ: GOCO) reported challenging Q2 2025 results, with net revenues declining 11.2% year-over-year to $94.0M. The company experienced significant decreases in partner revenue (-44.4%) and non-agency revenue (-79.4%), partially offset by growth in GoHealth Protect segment.

The company secured $115M in new and rolled-up loans and amended its credit agreement to waive near-term principal payments. Q2 resulted in a $115.9M net loss, including a $53M intangible asset impairment charge, though adjusted EBITDA showed slight improvement to -$11.3M year-over-year. Cost efficiency improved with marketing and consumer care expenses declining 26% and 33% respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
none
-
Rhea-AI Summary

GoHealth (NASDAQ: GOCO) has announced significant strategic capital and governance actions to enhance its financial flexibility. The company secured a new $80 million senior secured superpriority term loan facility plus $35 million in roll-up loans to support working capital ahead of the Medicare annual enrollment period.

Key actions include amending the existing credit agreement to waive principal payments through 2026, creating a $250 million debt basket capacity for transformative transactions, and issuing 4.7 million shares of Class A common stock to lenders. The company also appointed three new directors while accepting resignations from three existing board members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.19%
Tags
-
Rhea-AI Summary

GoHealth (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, has scheduled an announcement regarding strategic capital and governance actions along with its Q2 2025 financial results for August 7, 2025.

CEO Vijay Kotte and CFO Brendan Shanahan will host a conference call and webcast at 8:00 a.m. ET to discuss these developments. The presentation will be accessible through GoHealth's Investor Relations website, with a replay available after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.77%
Tags
Rhea-AI Summary

GoHealth (NASDAQ: GOCO), a health insurance marketplace specializing in Medicare Advantage plans, has secured an amended credit agreement with its lenders. The amendment provides covenant adjustments and extends the company's revolving credit facility maturity to September 30, 2025.

The agreement includes consent for GoHealth to pursue receivables financing, including potential securitization transactions, as part of a broader financing plan. This comprehensive plan aims to address the company's recent going concern position and strengthen its financial foundation for future growth.

CEO Vijay Kotte emphasized that the amendment demonstrates stakeholder support and enables the company to focus on long-term strategic priorities while maintaining its leadership position in the Medicare consumer support sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
none
-
Rhea-AI Summary

GoHealth Inc. (NASDAQ: GOCO) reported strong financial results for Q1 2025, with net revenues increasing 19.1% year-over-year to $221.0 million. The company demonstrated significant operational improvements, achieving a 40.2% increase in submissions to 303,026 compared to 216,148 in Q1 2024.

The Medicare-focused digital health marketplace provider posted an operating income of $6.7 million, marking a notable turnaround from the previous year's loss. Additionally, Adjusted EBITDA grew by 56.4% to $45.1 million. During the quarter, GoHealth also announced the launch of its new product, GoHealth Protect.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
none
-
Rhea-AI Summary
GoHealth (NASDAQ: GOCO) reported strong Q1 2025 financial results with notable improvements across key metrics. The company achieved net revenues of $221.0 million, up 19.1% year-over-year, and reduced its net loss to $9.8 million, a 54.2% improvement from the previous year. Adjusted EBITDA grew 56.4% to $42.1 million. Operational metrics showed significant progress with Submissions increasing 40.2% to 303,026, while Direct Operating Cost per Submission improved 18.4% to $522. The company also launched GoHealth Protect, expanding into guaranteed acceptance life insurance to diversify product offerings and enhance customer relationships. Management emphasized their focus on platform refinement, technology improvements, and strategic investments to drive better business outcomes and consumer experience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
Rhea-AI Summary
GoHealth (NASDAQ: GOCO) has issued a firm denial of allegations in a United States False Claims Act lawsuit regarding events from 2016 to 2021. The company, a leading health insurance marketplace and Medicare-focused digital health firm, refutes claims of receiving kickbacks or placing beneficiaries in suboptimal plans. GoHealth emphasizes its strong track record in serving special needs beneficiaries, who represent 35% of GoHealth enrollees compared to 17% of the general Medicare Advantage population. The company highlights its initiatives like the Low Income Subsidy team and PlanFit program, which focus on beneficiary needs without financial benefit to GoHealth. The company plans to vigorously defend itself while maintaining its mission to provide customers with healthcare decision support.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.25%
Tags
none
-
Rhea-AI Summary

GoHealth (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, has scheduled its first quarter 2025 financial results announcement for May 13, 2025. The results will be released in the morning, followed by a conference call and live audio webcast at 8:00 a.m. ET. CEO Vijay Kotte and CFO Brendan Shanahan will host the event, which will be accessible through GoHealth's Investor Relations website. An on-demand replay of the call will be made available shortly after the event concludes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.03%
Tags
-
Rhea-AI Summary

GoHealth Inc. (NASDAQ: GOCO) demonstrated robust performance in Q4 2024, with net revenues climbing 41% year-over-year to $389.1 million. The company's success was driven by a significant 67% increase in submissions, while achieving operational efficiencies with a 27% improvement in Direct Operating Cost per Submission to $501.

The Medicare-focused digital health marketplace provider reported a remarkable turnaround, posting a net income of $58.0 million, compared to a loss in the previous year. Additionally, the company's Adjusted EBITDA more than doubled to $117.8 million, reflecting successful strategic investments in technology and operational excellence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.38%
Tags
none
Rhea-AI Summary

GoHealth (NASDAQ: GOCO) reported strong Q4 2024 results with net revenues of $389.1 million, up 41% year-over-year. The company achieved significant growth with 481,445 submissions, a 67% increase from the previous year.

Q4 highlights include net income of $58.0 million, improving by $60.3 million, and Adjusted EBITDA of $117.8 million, up 107%. Direct Operating Cost per Submission improved 27% to $501.

Full-year 2024 performance showed net revenues of $798.9 million (9% growth), with 1,016,182 submissions (23% increase). The company reduced its net loss to $7.3 million, a $144.0 million improvement. Key achievements include successful refinancing of credit facility, implementation of PlanFit Save initiative, and supporting nearly 3 million Medicare consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.45%
Tags

FAQ

What is the current stock price of Gohealth (GOCO)?

The current stock price of Gohealth (GOCO) is $5.61 as of August 15, 2025.

What is the market cap of Gohealth (GOCO)?

The market cap of Gohealth (GOCO) is approximately 67.4M.
Gohealth, Inc.

Nasdaq:GOCO

GOCO Rankings

GOCO Stock Data

67.40M
5.11M
14.49%
53.6%
1.26%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
CHICAGO